• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[霍奇金淋巴瘤的长期(超过10年)生存情况]

[Long-term (over 10-years) survival in Hodgkin's disease].

作者信息

Kotlarek-Haus S, Gabryś K, Kuliszkiewicz-Janus M, Potoczek S, Kiełbiński M

机构信息

Katedry i Kliniki Hematologii Akademii Medycznej, Wrocławiu.

出版信息

Acta Haematol Pol. 1993;24(1):35-42.

PMID:8488735
Abstract

61 patients with Hodgkin's disease, i.e., 40.9% of all HD pts hospitalized in the years 1970-1981 are more than 10 years survivors: 46 are alive and 15 died of underlying disease or its complications. The most important prognostic factor at diagnosis was clinical advancement and the form A or B of HD. Age and sex also influenced survival but to a lesser degree. Patients living in CCR were more likely to have MC histology than those with relapsing disease, who more often showed LD and LP type. Among 5 persons with second neoplasms four disclosed NS type of HD. No statistical differences in clinical prognostic factors were encountered between further alive and those who died after more than 10-yrs. Almost all patients were able to normally continue their familial and professional lives.

摘要

61例霍奇金病患者,即1970 - 1981年间住院的所有霍奇金病患者中有40.9%存活超过10年:46例仍在世,15例死于基础疾病或其并发症。诊断时最重要的预后因素是临床分期以及霍奇金病的A或B型。年龄和性别也影响生存,但程度较小。与复发疾病患者相比,处于持续完全缓解(CCR)状态的患者更有可能具有混合细胞(MC)组织学类型,复发疾病患者更常表现为淋巴细胞消减(LD)和淋巴细胞为主(LP)型。在5例发生第二肿瘤的患者中,有4例表现为结节硬化(NS)型霍奇金病。存活超过10年的患者与死亡患者在临床预后因素方面未发现统计学差异。几乎所有患者都能够正常继续其家庭和职业生活。

相似文献

1
[Long-term (over 10-years) survival in Hodgkin's disease].[霍奇金淋巴瘤的长期(超过10年)生存情况]
Acta Haematol Pol. 1993;24(1):35-42.
2
Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease.霍奇金淋巴瘤的长期生存:死亡率、第二肿瘤、感染及心血管疾病的相对影响
Cancer J Sci Am. 1995 May-Jun;1(1):33-42.
3
Assessment of the prognostic impact of the Epstein-Barr virus-encoded latent membrane protein-1 expression in Hodgkin's disease.评估爱泼斯坦-巴尔病毒编码的潜伏膜蛋白-1表达在霍奇金淋巴瘤中的预后影响。
Br J Cancer. 2001 May 4;84(9):1227-34. doi: 10.1054/bjoc.2001.1774.
4
Interrelationship between several prognostic factors in Hodgkin's disease.霍奇金病中几种预后因素之间的相互关系。
Arch Geschwulstforsch. 1982;52(4):293-301.
5
Hodgkin's and non-Hodgkin's lymphoma of the head and neck.头颈部霍奇金淋巴瘤和非霍奇金淋巴瘤
Laryngoscope. 2001 Sep;111(9):1565-9. doi: 10.1097/00005537-200109000-00013.
6
[The significance of mediastinal involvement and other risk factors for survival in patients with Hodgkin's disease].[纵隔受累及其他危险因素对霍奇金病患者生存的意义]
Vnitr Lek. 1995 May;41(5):307-12.
7
Long-term cause-specific mortality of patients treated for Hodgkin's disease.接受霍奇金淋巴瘤治疗患者的长期特定病因死亡率。
J Clin Oncol. 2003 Sep 15;21(18):3431-9. doi: 10.1200/JCO.2003.07.131. Epub 2003 Jul 28.
8
Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR).首次复发或第二次缓解期霍奇金病的自体移植:来自自体血液和骨髓移植登记处(ABMTR)的报告
Bone Marrow Transplant. 2001 Feb;27(4):387-96. doi: 10.1038/sj.bmt.1702796.
9
Prognostic factors for survival after high-dose therapy and autologous stem cell transplantation for patients with relapsing Hodgkin's disease: analysis of 280 patients from the French registry. Société Française de Greffe de Moëlle.复发性霍奇金淋巴瘤患者大剂量治疗及自体干细胞移植后生存的预后因素:来自法国登记处280例患者的分析。法国骨髓移植协会
Bone Marrow Transplant. 1997 Jul;20(1):21-6. doi: 10.1038/sj.bmt.1700838.
10
Late effects after therapy of Hodgkin's disease: update 2003/04 on overwhelming post-splenectomy infections and secondary malignancies.霍奇金淋巴瘤治疗后的晚期效应:2003/04年关于脾切除术后严重感染和继发性恶性肿瘤的最新情况
Klin Padiatr. 2004 Nov-Dec;216(6):364-9. doi: 10.1055/s-2004-832340.